On January 20, 2025, Professor Paula I. Moreira from the University of Coimbra in Portugal won the 2024 First IETI George Perry Health and Neuroscience Award.
About Paula I. Moreira:
Moreira is an Associate Professor of Physiology at the Faculty of Medicine, University of Coimbra and leads the MitoBD (Mitochondria in Brain Disorders) research group at the Center for Neuroscience and Cell Biology, University of Coimbra (CNC-UC), Portugal. Moreira's group is mainly interested in elucidating the critical role of mitochondria (energy, homeostasis, and signals) in brain changes associated with metabolic and neurodegenerative diseases, with a special emphasis on Alzheimer's disease. Her research group is also interested in exploring the preventive and therapeutic potential of pharmacological and nonpharmacological strategies, such as mitochondrial modulators and hypoxic (pre)conditioning. Several experimental models such as isolated mitochondria, in vitro and in vivo/ex vivo models of disease and human samples are used to achieve the research goals. Moreira published more than 250 scientific peer-reviewed scientific articles and book chapters. She is co-Editor-in-Chief of Journal of Alzheimer's Disease, associate editor of Journal of Alzheimer's Disease Reports and Frontiers of Aging Neuroscience, section editor of BBA-Molecular Basis of Disease and belongs to the editorial board of Antioxidants and Redox Signaling and Aging Brain, among others. She was the recipient of the Stimulus to Research prize, in 2003, supported by the Calouste Gulbenkian Foundation, the L’Oréal for Women in Science Award, in 2008, supported by L’Oréal Portugal/UNESCO/FCT, and, in 2023, the RFS Award in Science for Antioxidants & Redox Signaling journal, supported by Mary Ann Liebert, Inc., in collaboration with the Rosalind Franklin Society.
Reasons for Award:
She is a top expert in studying the key role of mitochondria in brain changes related to metabolism and neurodegenerative diseases and has made outstanding contributions in the detailed practice of Alzheimer's disease.